<DOC>
	<DOCNO>NCT01275729</DOCNO>
	<brief_summary>The primary objective safely determine investigator identify severity Acute Kidney Injury ( AKI ) early course disease . Once enrolled investigator draw blood urine novel standard biomarkers . The investigator attempt determine biomarkers forecast course AKI ( need dialysis , death renal recovery ) . The investigator seek determine well physicians care AKI predict clinical course compare novel biomarkers AKI association clinical course 3 year patient outcome .</brief_summary>
	<brief_title>The Effect Loop Diuretics Severity Outcome Acute Kidney Injury</brief_title>
	<detailed_description>AKI common disease set critical illness carry extremely high morbidity mortality rate ( 50 % ) . Currently FDA approve therapuetic agent treatment AKI . There limited prospective evidence guide nephrologists term patient progress severe AKI set early AKI . Similarly , evidence guide nephrologists term patient completely recover renal function AKI . Thus need know early course AKI patient progress go require RRT . Additonally investigate long term patient outcome , 2-3 year index AKI admission .</detailed_description>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Sodium Potassium Chloride Symporter Inhibitors</mesh_term>
	<criteria>1 . 18 yrs old 2. increase serum creatinine 0.3 mg/dl within 48 hour increase great equal 150 % baselinie sustain oliguria ( UOP &lt; 0.5 cc/kg/hr 6 hour last 48hours ) 3. write informed consent 4. patient indwell bladder catheter 1 . Voluntary refusal 2 . Patients advance chronic kideny disease define baseline GFR &lt; 30 ml/min ( MDRD ) 3. history renal transplant 4 . Pregnant patient 5 . Allegery / Sensitivity Loop diuretic ( furosemide ) 6 . Prerenal AKI define FENa &lt; 1 % urinary cast underresuscitatedas per treat clinical team active bleed 7 . Post renal AKI evidence hydroureter clincal scenario wherein obstruction consider likely possibility</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Renal Replacement Therapy</keyword>
	<keyword>Diuretics</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Renal Insufficiency</keyword>
	<keyword>Furosemide</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Physiological Effects Drugs</keyword>
	<keyword>Biological Markers</keyword>
</DOC>